MAP3K7 and pneumoconiosis: By CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9-based genome-editing approach, we demonstrated that loss of TAK1 in lung tissues could alleviate silica-induced inflammation and fibrosis in silica-exposed mice with experimental pneumoconiosis.